Takeda CEO Christophe Weber aspires to make China its second most important market in the long run, accepting it as a major task in the future.
Stanford University School of Medicine Researchers have developed a magnetic wire that catches tumor cells flowing in the bloodstream. The wire, inserted into a vein, captures even limited tumor cells, ushering in a new means to detect cancer early.
Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
One of the largest clinical laboratories in the U.S, LabCorp Diagnostics of North Carolina faced a security breach by hackers forcing it to shut down on Sunday to combat the cyber attack.
In what seems to be a first of its kind research, Carnegie Mellon University and Yale University researchers have successfully cured a genetic condition in a mouse model with a gene editing technique. The findings of the study showcase a potential new opportunity for further research into treating genetic disorders in utero.
University of Adelaide researchers have designed a new molecule which targets a protein essential to the growth of most cancers. The protein target is called proliferating cell nuclear antigen (PCNA), also known as the human sliding clamp.
ElectroCore, famous for bioelectronic medicines, is associating with UpScriptHealth to deliver its gammaCore treatment via direct-to-patient telemedicine program. This non-invasive stimulation therapy of vagus nerve is used to treat migraines and episodic cluster headaches among the adults.
HCC or hepatocellular carcinoma can result in patients getting liver diseases such as viral hepatitis and non-alcoholic fatty liver disease with cirrhosis due to disease progression. New data from recent researches shows factors that improve early detection and diagnosis, and risks prior to HCC and during treatment.
Viral hepatitis is a major global health issue since it is the seventh leading cause of death worldwide. Around half of hepatitis-related deaths reported are due to the hepatitis B virus infection, which is transmitted through blood and body fluids.
A scientists team from the University of Sheffield have discovered that the human pathogen named Staphylococcus aureus especially MRSA (Methicillin-Resistant Staphylococcus aureus) uses non-threatening bacteria in the skin to initiate infection.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.